The Global Market for Testosterone Replacement Therapy (2019-2023): Leading Players are AbbVie, Bayer and Endo Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “Global Testosterone Replacement Therapy Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The testosterone replacement therapy market growth at a CAGR of more than (2%) during the forecast period.
The latest trend gaining momentum in the market is due to availability of such patient assistance programs, individuals are inclined toward buying these drugs, thereby increasing the growth of the market.
According to the report, one of the major drivers for this market is the increasing awareness about hypogonadism among the public and primary care physicians will drive the market.
Further, the report states that one of the major factors hindering the growth of this market is the availability of generics in the market acts as a challenge of the growth of the market.
Key PlayersAbbVie Bayer Endo Pharmaceuticals
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCTMarket segmentation by product Comparison by product Injections - Market size and forecast 2018-2023 Topicals - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPEGeographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors AbbVie Bayer Endo Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/34dm3s/the_global_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005316/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/10/2019 06:56 AM/DISC: 01/10/2019 06:56 AM